Study Finds Antidepressants Increase Risk of Death
From the New York Post: A recent study found that taking antidepressant drugs increases the risk of death by 33 percent. Those who take antidepressants were...
A Blow to STAT’s Credibility: Ghostwriting/PR Influence
From HealthNewsReview.org: STAT recently published an op-ed praising the role of drug company sales representatives. The physician listed as the author has now revealed that he did...
Replacing Pain with Pain: Hazards of Antidepressant Use for Chronic Pain Relief
The paradox of relieving chronic pain with an antidepressant (and a new set of symptoms).
New Tool to Assess Usefulness of Clinical Guidelines
From Medical Xpress: A new tool, G-TRUST (the Guideline Trustworthiness, Relevance, and Utility Scoring Tool) has been developed to help clinicians assess the usefulness of...
Psych Journal Issuing Caution About Torture Paper
From Retraction Watch: The psychology journal Teaching of Psychology plans to issue an editor's note about a controversial paper exploring the APA's involvement in the torture...
The Most Promoted Drugs are Those with Little Therapeutic Value, Study Finds
Majority of top-selling and most promoted drugs in Canada are rated as having very limited safety and efficacy.
The Smartphone Psychiatrist
In this piece for The Atlantic, David Dobbs delves into the life of former NIMH director Thomas Insel, his critiques of research within the field of...
Silicon Valley Courts Brand-Name Teachers, Raising Ethics Issues
From The New York Times: Tech companies are increasingly recruiting school teachers to help improve and promote their education tools in exchange for perks, including...
Disturbed Sleep Patterns May be Key to ADHD
From The Guardian: New research has linked symptoms of ADHD, such as struggling to concentrate, having too much energy, and being unable to control behavior,...
Has the Era of Gene Therapy Finally Arrived?
From Scientific American: The FDA has announced its approval of Kymriah, the first gene therapy in the U.S. However, gene therapy remains far from fulfilling...
New Nutrition Study Changes Nothing
From The Atlantic: The science of nutrition and healthy eating is not complicated and has remained relatively consistent for the past several years. However, the...
Proove Biosciences Sells Off Assets as CEO Departs
From STAT: Proove Biosciences, which sold dubious DNA tests to predict opioid addiction risk, has been placed into court-ordered receivership for restructuring and asset sale. Experts...
Good Psychologist, Bad Psychologist
In this episode on BBC Radio, psychiatrist Raj Persaud reports on the CIA's so-called "enhanced interrogation" program, which has frequently been characterized as torture. He discusses...
Science is Catching Up to the Buddha
From Big Think: In Robert Wright's new book Why Buddhism is True, he illustrates how contemporary science has confirmed some of the core tenets and beliefs...
MDMA Crossed a Hurdle on the Path to Being Legally Prescribed
From Yahoo! Finance: The Multidisciplinary Association for Psychedelic Studies (MAPS) has passed a major hurdle on the path to getting MDMA approved for medical use....
Researchers Question Add-On Treatment for ‘Schizophrenia’
A common practice when antipsychotics are found to be ineffective for schizophrenia is to prescribe a second, additional psychoactive medication. Now, a new study suggests that this practice is not supported by the research.
Feel Bad About Feeling Bad? Embrace Negative Emotions Instead
From Big Think: According to new research, habitually accepting negative emotions rather than criticizing or suppressing them positively impacts our long-term psychological health.
"There is a lot more...
Deprescribing: How to be on Less Medication for Healthier Aging
In this post for Better Health While Aging, Dr. Leslie Kernisan discusses the importance of making sure that older adults are taking the minimum amount...
Inappropriate Use of Antipsychotics on Adults with Intellectual and Developmental Disabilities
One-third of adults with an intellectual or developmental disability are dispensed antipsychotics, despite having no existing psychiatric diagnosis.
The State of the Evidence Base for Current Medical Products
In this post for Yale Law School's CRITical Thinking, Tom Jefferson discusses some of the factors that currently serve to undermine rational and ethical medical...
Emotional Intelligence Needs a Rewrite
From Nautilus: The traditional notion of emotional intelligence is based on two assumptions: that it is possible to detect others' emotions accurately, and that emotions...
The Concept of Schizophrenia is Coming to an End – Here’s Why
From The Conversation: Many researchers are beginning to acknowledge that the concept of "schizophrenia" as a discrete, hopeless, and deteriorating brain disease does not exist. In...
Abilify: The Drug That Could Gamble Your Life Away
On this episode of America's Lawyer, Mike Papantonio discusses the numerous lawsuits pending involving the anti-psychotic drug Abilify, which has caused plaintiffs to develop serious...
Time on a Therapist’s Couch Yields Personality Changes
From Ars Technica: A recent meta-analysis found that a variety of different therapeutic techniques result in positive personality changes. The two personality traits most impacted...
Biotech Exploits a Loophole in a Federal Transparency Law
From STAT: A small biotech company, AveXis, recently offered a $3,000 honorarium along with paid airfare and lodging to several experts to attend a so-called...
